Knoles

Knoles v. Teva Pharmaceuticals USA, Inc.

Good Law
United States District Court, Northern District of CaliforniaNovember 5, 20195:17-cv-06580California977 words

Opinion

Trial Court Opinion

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA SAN JOSE DIVISION 6 MARLESSA KNOLES, Case No. 17-cv-06580-BLF

Plaintiff,

ORDER DISMISSING SECOND

v. AMENDED COMPLAINT AS TO ALL

REMAINING DEFENDANTS; AND

TEVA PHARMACEUTICALS USA, INC.; DISMISSING ACTION WITHOUT

TEVA BRANDED PHARMACEUTICALS PREJUDICE

PRODUCTS R&D, INC.; FEI WOMEN’S

HEALTH LLC; ORTHO-MCNEIL

PHARMACEUTICAL, LLC; and

DURAMED PHARMACEUTICALS,

13 Defendants. 14 15 On October 17, 2019, the Court granted the Teva Defendants’ motion to dismiss the second amended complaint (“SAC”) for lack of personal jurisdiction, without leave to amend. See Order, ECF 81. The Court also ordered Plaintiff to show cause, in writing and on or before October 31, 2019, why the second amended complaint should not be dismissed with respect to the three remaining defendants, FEI Women’s Health LLC, Ortho-McNeil Pharmaceutical, LLC, and Duramed Pharmaceuticals. See Order, ECF 81. The Court stated its view that…

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.